Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of TBPH will decline by -0.28% over the next 2 Weeks and hit $16.32 by Wednesday, June 24, 2026. In that time frame, TBPH's share price is expected to range between $16.07 and $16.55.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jun 24, 2026 | 16.07 | 16.32 | 16.55 |
| Jun 23, 2026 | 16.08 | 16.31 | 16.55 |
| Jun 22, 2026 | 16.10 | 16.33 | 16.56 |
| Jun 19, 2026 | 16.24 | 16.47 | 16.70 |
| Jun 18, 2026 | 16.15 | 16.39 | 16.62 |
| Jun 17, 2026 | 16.14 | 16.38 | 16.61 |
| Jun 16, 2026 | 16.13 | 16.37 | 16.60 |
| Jun 15, 2026 | 16.18 | 16.39 | 16.61 |
| Jun 12, 2026 | 16.30 | 16.52 | 16.74 |
| Jun 11, 2026 | 16.21 | 16.44 | 16.67 |
TBPH shares fell -0.73% in Wednesday, June 10, 2026's trading session, dropping from a previous close of $16.49 to move at $16.37. The stock demonstrated notable intraday movement (see TBPH's key stats for a full breakdown), fluctuating between $16.30 and $16.62, a +1.96% trading range. While recent weeks have seen some volatility, TBPH has managed to secure a +0.68% gain over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 341.13K shares changing hands, 9.03K more than the previous session. This amounted to $5.58M in total market activity.
Will TBPH Continue Its Upward Trend?
According to analyst ratings and projections for TBPH, Theravance Biopharma, Inc. shares are anticipated to increase by +1.12%, potentially reaching $16.55 per share by June 24, 2026. Short-term technical indicators currently suggest a neutral sentiment for TBPH. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 12 positive trading days within the past 30 sessions. Based on the TBPH stock forecast, now is a good time to buy TBPH stock because its current trading price is +0.28% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on TBPH covering social and institutional perspectives.
TBPH Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into TBPH's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 50.19% to 53.13%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 49.39%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 51.01%, maintains a neutral outlook for the long term. Insights into TBPH's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Theravance Biopharma Short-Term Forecasts
TBPH Forecast For Next 5 Days
Our algorithm anticipates Theravance Biopharma (TBPH) stock could hit $15.73 by Jun 17, 2026. This represents a -3.90% rise from today's price, following a +3.92% change over the past five days.
TBPH Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Theravance Biopharma, Inc. (TBPH) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $16.32, which would mean a -0.31% decrease from the current price of $16.37. Projections for this period range from a high of $17.53 to a low of $15.02.
TBPH Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Theravance Biopharma's price over the next three months point to a rise. TBPH stock is expected to peak at $18.07 on Sep 11, 2026 after potentially dipping to $15.10 on Aug 05, 2026. On average, TBPH is likely to trade around $16.52 in the coming 90 days.
Theravance Biopharma Stock Forecast 2025
Based on our predictive models, Theravance Biopharma (TBPH) is expected to trade between $15.10 and $19.66 throughout 2026. This would result in an average price of $16.96, potentially offering investors a +3.60% return from current levels.
Theravance Biopharma, Inc. Monthly Forecast 2026–2027
June 2026
According to our latest forecast models, Theravance Biopharma, Inc. (TBPH) is positioned to show a strong performance in June 2026. The price is predicted to move between $15.24 and $17.60, settling at an average of $16.43. This could translate to a +0.37% gain.
July 2026
Based on current market signals, Theravance Biopharma, Inc. is projected to trend july 2026. We forecast a trading range from $15.21 to $17.89, with a likely average price of $16.74. Investors could expect a potential return of +2.26%.
August 2026
Our predictive algorithms indicate Theravance Biopharma, Inc. stock may see a shift in August 2026. The expected range spans $15.10–$17.54, with an average target of $16.30. This represents a cautious outlook and a possible loss of -0.43%.
September 2026
Analyzing established trends, Theravance Biopharma, Inc. looks set to move in September 2026. Projections place the stock between $15.48 and $18.31, averaging around $16.96. This suggests a +3.60% gain from current levels.
October 2026
Market indicators suggest Theravance Biopharma, Inc. could experience notable changes during October 2026. Prices could fluctuate within $15.60 to $18.36, with a midpoint forecast of $17.02. The stock might deliver a +3.97% gain.
November 2026
Forecasting for November 2026, models estimate that Theravance Biopharma, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $16.12 and $19.66, averaging $17.40. This signals a positive trajectory with potential returns around +6.29%.
December 2026
According to our latest forecast models, Theravance Biopharma, Inc. (TBPH) is positioned to show a strong performance in December 2026. The price is predicted to move between $16.22 and $18.99, settling at an average of $17.68. This could translate to a +8.00% gain.
January 2027
Based on current market signals, Theravance Biopharma, Inc. is projected to trend january 2027. We forecast a trading range from $15.90 to $18.53, with a likely average price of $17.28. Investors could expect a potential return of +5.56%.
February 2027
Our predictive algorithms indicate Theravance Biopharma, Inc. stock may see a shift in February 2027. The expected range spans $16.41–$19.28, with an average target of $17.96. This represents a positive outlook and a possible gain of +9.71%.
March 2027
Analyzing established trends, Theravance Biopharma, Inc. looks set to move in March 2027. Projections place the stock between $16.62 and $19.19, averaging around $18.00. This suggests a +9.96% gain from current levels.
April 2027
Market indicators suggest Theravance Biopharma, Inc. could experience notable changes during April 2027. Prices could fluctuate within $17.14 to $19.51, with a midpoint forecast of $18.31. The stock might deliver a +11.85% gain.
May 2027
Forecasting for May 2027, models estimate that Theravance Biopharma, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $17.12 and $19.98, averaging $18.66. This signals a positive trajectory with potential returns around +13.99%.
June 2027
According to our latest forecast models, Theravance Biopharma, Inc. (TBPH) is positioned to show a strong performance in June 2027. The price is predicted to move between $16.96 and $19.20, settling at an average of $18.08. This could translate to a +10.45% gain.
TBPH's history of dividends and stock splits also plays a role in long-term investor confidence.

